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Abstract
Introduction This report describes the case mix, outcome and
activity for admissions to intensive care units (ICUs) of patients
who require prior chronic renal dialysis for end-stage renal
failure (ESRF), and investigates the effect of case mix factors on
outcome.
Methods This was a secondary analysis of a high-quality clinical
database, namely the Intensive Care National Audit & Research
Centre (ICNARC) Case Mix Programme Database, which
includes 276,731 admissions to 170 adult ICUs across
England, Wales and Northern Ireland from 1995 to 2004.
Results During the eight year study period, 1.3% (n = 3,420) of
all patients admitted to ICU were receiving chronic renal dialysis
before ICU admission. This represents an estimated ICU
utilization of six admissions (32 bed-days) per 100 dialysis
patient-years. The ESRF group was younger (mean age 57.3
years versus 59.5 years) and more likely to be male (60.2%
versus 57.9%) than those without ESRF. Acute Physiology and
Chronic Health Evaluation II score and Acute Physiology Score
revealed greater severity of illness on admission in patients with
ESRF (mean 24.7 versus 16.6 and 17.2 versus 12.6,
respectively). Length of stay in ICU was comparable between
groups (median 1.9 days versus 1.8 days) and ICU mortality was
only slightly elevated in the ESRF group (26.3% versus 20.8%).
However, the ESRF group had protracted overall hospital stay
(median 25 days versus 17 days), and increased hospital
mortality (45.3% versus 31.2%) and ICU readmission (9.0% vs.
4.7%). Multiple logistic regression analysis adjusted for case
mix identified the increased hospital mortality to be associated
with increasing age, emergency surgery and nonsurgical cases,
cardiopulmonary resuscitation before ICU admission and
extremes of physiological norms. The adjusted odds ratio for
ultimate hospital mortality associated with chronic renal dialysis
was 1.24 (95% confidence interval 1.13 to 1.37).
Conclusion Patients with ESRF admitted to UK ICUs are more
likely to be male and younger, with a medical cause of
admission, and to have greater severity of illness than the non-
ESRF population. Outcomes on the ICU were comparable
between the two groups, but those patients with ESRF had
greater readmission rates, prolonged post-ICU hospital stay and
increased post-ICU hospital mortality. This study is by far the
largest comparative outcome analysis to date in patients with
ESRF admitted to the ICU. It may help to inform clinical decision-
making and resource requirements for this patient population.
Introduction
End-stage renal failure (ESRF) is a common, chronic disorder.
Advances in dialysis services over recent years have resulted
in patients living increasingly independent and healthier lives.
Despite this, patients with ESRF are prone to repeated hospi-
tal admissions, some of which require admission to an
intensive care unit (ICU). These admissions are predominantly
related to the comorbidities associated with ESRF; of these,
vascular access related infection and cardiovascular disease
are the most common causes of admission to hospital [1].
APACHE = Acute Physiology and Chronic Health Evaluation; ARF = acute renal failure; CMP = Case Mix Programme; CPR = cardiopulmonary resus-
citation; ESRF = end-stage renal failure; ICNARC = Intensive Care National Audit & Research Centre; ICU = intensive care unit; OR = odds ratio; 
ROC = receiver operating characteristic.
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A number of factors have led to a rapidly expanding ESRF
population. Chief among these are issues such as increased
life expectancy, resulting in the average age of the population
rising, and the expanding population with predisposing
chronic diseases such as diabetes mellitus [2,3]. The UK
Renal Registry estimates the current incidence and preva-
lence of dialysis-dependent ESRF to be around 100 and 700
per million of the UK population, respectively.
Although it is perceived that the need for critical care services
in the ESRF population is high and it is expected that this need
will continue to increase [4], there is no adequate estimate of
the actual critical care services needed. Moreover, there is no
planning for critical care resource requirement to service the
current ESRF population. Until recently, it was assumed that
patients with ESRF admitted to critical care have considerably
increased morbidity and mortality in comparison with the gen-
eral ICU admission population. The recognized high ICU mor-
tality of patients who develop acute renal failure (ARF) may in
some cases be influencing the decision to admit to the ICU
patients who require dialysis for ESRF. This assumption could
lead to therapeutic nihilism limiting access to critical care for
the ESRF population. Recently, studies including limited num-
bers of patients have examined this issue. Two [5,6] sug-
gested that in fact the mortality of the ESRF population in the
critical care setting is only moderately raised above the non-
ESRF patient group, and nothing like the increased mortality
seen with ARF. A third report, however, suggests that patients
with ESRF in the critical care setting do have significantly
increased mortality [7]. These reports also raise concerns
about the predictive value of general ICU severity scoring sys-
tems to predict outcome in patients with ESRF in the critical
care setting [5,6].
The need for high-quality data on outcomes, and the factors
that are predictive of them, in ESRF patients in the critical care
setting is required to confirm or refute these previous findings.
Availability of such data will help to inform service planning and
guide clinical decision making in this patient population. In the
present study a large, high-quality, clinical database was used
to identify admissions to ICUs across England, Wales and
Northern Ireland of patients with ESRF who were already
receiving chronic dialysis. We report, for the first time, national,
baseline information that will be useful for both local bench-
marking and for dictating future policy. This report describes
case mix and factors that are predictive of outcome in patients
with ESRF admitted to the ICU, as a first step toward achiev-
ing the desired service goals.
Materials and methods
Case Mix Programme Database
The Case Mix Programme (CMP) is a national comparative
audit of adult, general critical care units in England, Wales and
Northern Ireland coordinated by the Intensive Care National
Audit & Research Centre (ICNARC). Data were extracted for
276,731 admissions to 170 intensive care units (ICUs) from
the CMP Database, covering the period from December 1995
to January 2004. Details of the data collection and validation
were reported previously [8].
Selection of cases
Admissions were identified by the recording of the need for
chronic renal replacement therapy, as part of the chronic
health conditions for Acute Physiology and Chronic Health
Evaluation (APACHE) II scoring [9]. The need for chronic renal
replacement therapy is defined as, 'admission currently
requires chronic renal replacement therapy (either chronic
haemodialysis, chronic haemofiltration, or chronic peritoneal
dialysis) for irreversible renal disease', and must be docu-
mented before admission or on admission to the CMP unit.
Data
Data were extracted on case mix, outcome and activity, as
defined below.
Case mix
Age at admission and sex were extracted. Admissions of
patients who were mechanically ventilated during the first 24
hours in the ICU were identified by recording of mechanical
ventilation on admission to the unit or by recording of a lowest
or highest ventilated respiratory rate during the first 24 hours
after admission. The following physiological variables,
selected a priori, were extracted from records of the first 24
hours in the ICU: highest serum creatinine, lowest serum albu-
min and lowest haematocrit.
Acute severity was measured using the APACHE II Acute
Physiology Score and the APACHE II score [9]. The former
encompasses a weighting for acute physiology (defined by
derangement from the normal range for 12 physiological vari-
ables during the first 24 hours in the ICU). The latter addition-
ally encompasses a weighting for age and for past medical
history of specified serious conditions.
Surgical status was defined as either nonsurgical, elective sur-
gery, or emergency surgery, based on the source of admission
to the CMP unit and the National Confidential Enquiry into
Perioperative Deaths (NCEPOD) classification of surgery, as
was previously described [8].
Organ system failures were assessed according to the
method proposed by Knaus and coworkers [10], based on
physiological data from the first 24 hours in the ICU. The organ
system failures assessed are cardiovascular failure, respiratory
failure, renal failure, haematological failure and neurological
failure. Note that all patients on chronic renal dialysis are
excluded from the renal failure category, and so admissions in
the study population had a possible range from zero to four
organ system failures.
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Outcome
Survival data were extracted at discharge from the CMP unit
and at ultimate discharge from hospital.
Activity
Length of stay in ICU was calculated in fractions of days from
the dates and times of admission and discharge from the CMP
unit. Length of stay in hospital was calculated in days from the
dates of original admission to and ultimate discharge from an
acute hospital. Transfers in from another ICU were identified
as admissions whose source of admission to the CMP unit
was ICU in the same or other hospital. Readmissions to ICU
within the same hospital stay were identified from the post-
code, date of birth and sex, and confirmed by the participating
units. Treatment withdrawal was defined as the documented
decision to withdraw all active treatment, other than comfort
measures. The destination following discharge from the CMP
unit was also extracted for all admissions of patients who were
discharged alive.
Analyses
Case mix, outcome and activity were described for all patients
admitted who required chronic renal dialysis and for the
remainder of the CMP Database, excluding admissions of
patients for whom there was no evidence available to assess
past medical history. The primary reason for admission to the
CMP unit (coded using the ICNARC Coding Method [11])
was tabulated for patients requiring chronic renal dialysis. Ulti-
mate hospital mortality, by number of organ system failures,
was compared for patients requiring and not requiring chronic
renal dialysis.
The outcomes of patient admitted who required chronic renal
dialysis, as compared with other patients, adjusted for case
mix factors, were assessed with a multiple logistic regression
model on ultimate hospital mortality. Case mix adjustment was
performed including the following factors: age, sex, surgical
status, APACHE II chronic health conditions (excluding
chronic renal replacement therapy), cardiopulmonary resusci-
tation (CPR) during 24 hours before admission to the CMP
unit, Glasgow Coma Score (lowest during the first 24 hours in
the CMP unit or the pre-sedation value for patients who were
sedated or paralyzed and sedated for the first 24 hours),
number of organ system failures, sepsis (defined physiologi-
cally using data from the first 24 hours following admission to
the CMP unit [12]) and all of the physiological variables
included in the APACHE II model plus serum albumin. Age,
Glasgow Coma Score and number of organ system failures
were modelled as having a linear effect on the log odds. All
other variables were modelled categorically, using the catego-
ries from APACHE II or APACHE III [13] as appropriate for the
physiological variables, but fitting new weights to each cate-
gory. When a variable was present in both APACHE II and
APACHE III, the categorization giving the greatest number of
categories was selected. Categories from APACHE II were
used to model temperature, mean arterial pressure, arterial pH,
serum sodium, serum potassium, serum creatinine, haemat-
ocrit and white blood cell count. Categories from APACHE III
were used to model heart rate, respiratory rate, oxygenation
(either arterial to alveolar oxygen difference or arterial oxygen
tension, depending on the fractional inspired oxygen level) and
serum albumin. Patients whose records were lacking age, sex,
surgical status, or any routinely measured physiological varia-
bles (temperature, blood pressure, heart rate, or respiratory
rate) were excluded from the modelling. All other missing val-
ues were assumed to be normal and were placed in the cate-
gory corresponding to zero APACHE II/III points.
The same multiple logistic regression approach was used to
model the effects of the above parameters on ultimate hospital
mortality within the group of patients requiring chronic renal
dialysis. Because this involved a much smaller number of
admissions, the APACHE II/III categories were first collapsed
by combining adjacent categories such that each category
contained at least 50 admissions. Results of this model were
compared with the same model fitted in the group of patients
not requiring chronic renal dialysis by introducing interaction
terms.
All logistic regression models were assessed for discrimina-
tion by the area under the receiver operating characteristic
(ROC) curve [14], and for overall fit by Brier's score (mean
square error between outcome and prediction) [15] and Sha-
piro's R statistic (geometric mean probability assigned to the
event that occurred) [16].
The usefulness of the newly-developed ESRF-specific model
in discriminating between survivors and nonsurvivors among
ESRF patients and non-ESRF patients was assessed using
ROC curves. The utility of the model was also compared with
the performance of the APACHE II score in these groups.
All analyses were performed using Stata 8.2 (StataCorp LP,
College Station, TX, USA).
Results
Data
Of 276,731 patients admitted to 170 adult ICUs in the CMP
Database, for 270,972 (97.9%) there was sufficient evidence
to assess past medical history. Of these, 3,420 (1.3%) were
identified as requiring chronic renal dialysis. Figure 1 shows
projected ICU admissions for the chronic renal dialysis popu-
lation and the total population for the years of the study. In
2003, we project that there were 1,172 admissions to ICUs in
England, Wales and Northern Ireland of patients requiring
chronic renal dialysis, occupying a total of 5,920 ICU bed-
days. The UK Renal Registry Report 2004 [17] estimated the
total number of adult patients receiving renal replacement
therapy in 2003 in England, Wales and Northern Ireland to be
33,929, of which 54% received dialysis. Based on these fig-
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ures, ICU utilization in 2003 was six ICU admissions or 32 ICU
bed-days per 100 dialysis patients. The ICU utilization by
patients with ESRF remained stable over the past five study
years, whereas the numbers of patients treated nationally for
ESRF increased.
Case mix, outcome and activity
Table 1 describes measures of case mix, outcome and activity
for patients requiring chronic renal dialysis and admissions of
all other patients for whom evidence was available to allow
assessment of past medical history.
Patients requiring chronic renal dialysis were slightly younger
than other patients (mean age 57.3 years versus 59.5 years)
and were slightly more likely to be male (60.2% versus
57.9%). They were more likely to have received CPR during
the 24 hours before admission to the CMP unit (13.6% versus
7.3%). They had greater creatinine (mean 6.5 mg/l versus 1.5
mg/l) and lower haematocrit (mean 26.9% versus 31.3%).
Overall acute severity of illness was worse, as indicated by
higher Acute Physiology Score (mean 17.2 versus 12.6) and
APACHE II score (mean 24.7 versus 16.6). Overall, 67% of all
patients requiring chronic renal dialysis were nonsurgical, as
compared with 56% of other patients. The pattern of organ
system failures was similar for both groups.
Crude mortality in the CMP unit was 26.3% for patients requir-
ing chronic renal dialysis, as compared with 20.8% for other
patients. At ultimate hospital discharge, mortality in these
patients was 45.3% as compared with 31.2% in the reference
group.
Patients requiring chronic renal dialysis had a similar length of
stay in the CMP unit to that of other patients, but they had a
longer stay in hospital (median 25 days versus 17 days for sur-
vivors; 15.5 days versus 8 days for nonsurvivors; Figure 2).
Patients requiring chronic renal dialysis were more likely to be
readmitted to the ICU during the same hospital stay (9.0% ver-
sus 4.7%), although the rate of direct transfers between ICUs
was similar for the two groups of patients. There was no sig-
nificant difference between the groups in the decision to with-
draw treatment (9.8% versus 10.7% in non-ESRF and ESRF
populations, respectively). The patterns of destination follow-
ing discharge were broadly similar, although patients requiring
chronic renal dialysis were slightly more likely to be transferred
to high dependency care and were considerably more likely to
be transferred to an 'other intermediate care area', which is the
category containing renal units.
Of the 3,420 patients requiring chronic renal dialysis, 3,189
(93.2%) had a complete primary reason for admission speci-
fied, 230 (6.7%) had a partially coded reason for admission,
and the remaining one admission (0.03%) had no reason for
admission recorded. Of the 3,189 patients with a complete
primary reason for admission, 275 (8.6%) had chronic renal
failure recorded as the reason for admission (Table 2). The
most common other reasons for admission were septic shock
(179 [5.6%]) and pneumonia either with no organism isolated
(167 [5.2%]) or a bacterial pathogen isolated (94 [2.9%]).
Hospital mortality increased steeply with number of organ sys-
tem failures (Table 3). It was higher in patients requiring
chronic renal dialysis, particularly at low numbers of organ sys-
tem failures.
Case mix adjusted effect of chronic renal dialysis on 
ultimate hospital mortality
After adjusting for case mix factors of age, sex, surgical status,
APACHE II physiology variables, serum albumin and the
number of nonrenal organ system failures (see Materials and
methods, above), the odds ratio for ultimate hospital mortality
associated with chronic renal dialysis was 1.24 (95% confi-
dence interval [CI] 1.13 to 1.37) as compared with a crude
odds ratio before case mix adjustment of 1.82 (95% CI 1.69
to 1.96). The case mix adjusted model had an area under the
ROC curve of 0.857 (95% CI 0.855 to 0.858), a Brier's score
(B) of 0.138 and a Shapiro's R of 0.653 when assessed for all
admissions.
Relationship of case mix factors with ultimate hospital 
mortality
Table 4 presents the results of the multiple logistic regression
analysis of case mix factors on ultimate hospital mortality in the
group of chronic renal dialysis patients. The following factors
were associated with increased odds of hospital mortality:
older age, emergency surgery and nonsurgical cases (as com-
pared with elective surgery), presence of other chronic health
conditions, CPR during the 24 hours before admission to the
CMP unit, hospital stays of longer than one week before
Figure 1
Projected total admissions to ICU and number requiring chronic renal dialysis
dialysis. The figures relate to England, Wales and Northern Ireland. 
ESRF, end-stage renal failure (requiring chronic renal dialysis); ICU, 
intensive care unit.
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Table 1
Case mix, outcome and activity for patients admitted to ICUs requiring chronic renal dialysis as compared with other patients
Parameter Patients requiring chronic renal 
dialysis 
(n = 3,420)




Case mix Age (mean [SD]; years) 57.3 (15.8) 59.5 (19.6) < 0.001
Male sex (n [%]) 2,058 (60.2) 154,780 (57.9) 0.006
CPR before admission (n [%]) 466 (13.6) 19,535 (7.3) < 0.001
Mechanically ventilated (n [%]) 2,107 (61.8) 167,840 (63.1) 0.135
Highest serum creatinine (mean [SD]; mg per 100 ml/mmol per l]) 6.5 (3.2)/575 (283) 1.5 (1.3)/133 (115) < 0.001
Lowest serum albumin (mean [SD]; g/l) 22.9 (7.7) 23.4 (8.5) 0.001
Lowest haematocrit (%)/haemoglobin (g/dl) (mean [SD]) 26.9 (5.9)/9.0 (2.0) 31.3 (6.6)/10.4 (2.2) < 0.001
APACHE II APS scorea (mean [SD]) 17.2 (6.5) 12.6 (6.7) <0.001
APACHE II scorea (mean [SD]) 24.7 (7.0) 16.6 (7.3) < 0.001
Surgical status (n [%]) < 0.001
Nonsurgical 2,282 (66.7) 150,350 (56.2)
Elective surgery 592 (17.3) 66,017 (24.7)
Emergency surgery 545 (16.0) 50,947 (19.1)
Number of nonrenal organ system failuresb (n [%]) < 0.001
None 1,156 (33.8) 107,140 (40.0)
1 1,223 (35.8) 99,299 (37.1)
2 743 (21.7) 46,447 (17.4)
3+ 298 (8.7) 14,666 (5.5)
Outcome Mortality in ICU (n [%]) 898 (26.3) 55,547 (20.8) < 0.001
Ultimate hospital mortality (n [%]) 1,379 (45.3) 77,869 (31.2) < 0.001
Activity ICU LOS (median [IQR]; days)
Survivors 1.9 (0.9–4.2) 1.8 (0.9–4.5) 0.507
Nonsurvivors 2.0 (0.6–6.0) 1.9 (0.7–6.1) 0.843
Total hospital LOS (median [IQR]; days)
Survivors 25 (13–49) 17 (9–33) < 0.001
Nonsurvivors 15.5 (5–35) 8 (2–21) < 0.001
Transfers from another ICU (n [%]) 120 (3.5) 10,508 (3.9) 0.210
Readmissions within hospital stay (n [%]) 306 (9.0) 12,676 (4.7) < 0.001
Treatment withdrawn (n [%]) 364 (10.7) 26,119 (9.8) 0.087
Destination following discharge (n [%]) < 0.001
Ward, same hospital 1,788 (70.9) 155,487 (73.4)
Recovery, same hospital 14 (0.6) 975 (0.5)
ICU, same hospital 9 (0.4) 1,580 (0.8)
HDU, same hospital 295 (11.7) 28,695 (13.6)
Other intermediate care, same hospital 156 (6.2) 4,573 (2.2)
ICU, other hospital 94 (3.7) 10,898 (5.2)
HDU, other hospital 16 (0.6) 850 (0.4)
Other hospital, not ICU/HDU 137 (5.4) 6,088 (2.9)
Normal residence 12 (0.5) 2,662 (1.3)
aAcute Physiology and Chronic Health Evaluation (APACHE) II exclusions: age < 16 years; intensive care unit (ICU) stay < 8 hours; readmissions within same hospital 
stay; transfers from another ICU; admissions following coronary artery bypass grafting; and admissions for primary burns. bOrgan system failures assessed 
physiologically according to the method of Knaus and coworkers [10]. APS, Acute Physiology Score; CPR, cardiopulmonary resuscitation; HDU, high dependency unit; 
IQR, interquartile range; LOS, length of stay; SD, standard deviation.
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admission to the CMP unit, lower mean arterial pressure, high
heart rate, high respiratory rate, extreme oxygenation values
(high alveolar to arterial oxygen difference or low arterial oxy-
gen tension), low arterial pH, low serum sodium, low serum
albumin, extreme (high or low) white blood count, low Glas-
gow Coma Score, increasing number of organ system failures,
and sepsis during the first 24 hours in the CMP unit. Among
patients requiring chronic renal dialysis, this model had dis-
crimination and fit statistics as follows: area under the ROC
curve 0.817 (95% CI 0.802 to 0.832), B = 0.173 and R =
0.595.
When compared with the same model fitted in patients not
requiring chronic renal dialysis, a number of factors exhibited
a significantly different relationship with hospital mortality. Fac-
tors with a weaker association with hospital mortality in the
ESRF population were age, surgical status, oxygenation,
potassium and haematocrit. Adjusting for all other factors, a
high mean arterial pressure (≥ 130 mmHg) appeared to exhibit
a protective effect in the ESRF population, whereas in the non-
ESRF population it was harmful (odds ratio 0.62 versus 1.24).
Figure 2
Length of stay in the ICU and in hospitali i l. Box indicates median and quartiles; whiskers indicate 5th and 95th percentiles. ESRF, end-stage renal fail-
ure (requiring chronic renal dialysis); ICU, intensive care unit.
Table 2
Most common primary reasons for admission to the ICU for 
admissions requiring chronic renal dialysis
Primary reason for admission n (%)
Chronic renal failure 275 (8.6)
Septic shock 179 (5.6)
Pneumonia, no organism isolated 167 (5.2)
Bacterial pneumonia 94 (2.9)
Septicaemia 90 (2.8)
Status epilepticus or uncontrolled seizures 87 (2.7)
Cardiogenic pulmonary oedema 84 (2.6)
Hypovolaemic shock 84 (2.6)
Cardiogenic shock 79 (2.5)
CAPD related peritonitis 75 (2.4)
CAPD, Continuous ambulatory peritoneal dialysis; ICU, intensive 
care unit.
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Discrimination of the APACHE II score and ESRF-
specific model
The area under the ROC curve for the APACHE II score was
0.721 (95% CI 0.701 to 0.741) for the ESRF group as com-
pared with 0.805 (95% CI 0.803 to 0.807) for the non-ESRF
group (P < 0.001; Figure 3). This demonstrates that APACHE
II scores are less sensitive in the ESRF population than in the
non-ESRF population in discriminating between survivors and
nonsurvivors. Discrimination was improved by using the new
ESRF-specific model, but it was still worse among the ESRF
group than in the non-ESRF group (area under the ROC curve
0.817 [95% CI 0.802 to 0.832] versus 0.853 [95% CI
0.851–0.854]; P < 0.001).
Discussion
The aim of this study was to describe the case mix and out-
come of adult admissions to ICU of patients with ESRF in the
UK. To our knowledge four previous studies have reported on
outcomes of patients with ESRF in the ICU, three of which
were single centre and all of which included relatively small
populations [5-7,18]. These highlighted the need for a large
multicentre study to describe conclusively the admission of
patients with ESRF to ICUs and their outcomes. Over the
examined eight-year period, 1.2% (n = 3,420) of all patients
admitted to the ICU (n = 276,731) had ESRF and were receiv-
ing dialysis (either chronic peritoneal or haemodialysis). This
figure is considerably lower than the 3.7% observed in the
USA [6] and 8.6% in a single centre study conducted in a
French ICU [18]. This discrepancy is not surprising, given the
limitations of single centre studies and the considerable differ-
ences in the utilization of both renal replacement therapy and
ICU resources between different European and North Ameri-
can countries.
During the study period there was considerable expansion in
the total number of admissions, but this was not matched by
an expansion in the number of dialysis patients being admitted
to ICU. This is particularly surprising because the total UK dial-
ysis population increased by about 50% over the same time
period and merits further investigation. Based on 2003 data,
these figures give an annual ICU utilization of 1,172 admis-
sions, or six admissions per 100 patients in the dialysis
population. This compares to an overall ICU utilization of two
admissions per 1,000 of the general population of England,
Wales and Northern Ireland. It must be stressed that this utili-
zation represents the current usage but not the need for ICU
care among patients with ESRF, which is almost certainly
greater and will rise as the population grows.
As seen in the study conducted by Dara and coworkers [5],
admission to ICU of patients with ESRF is more common in
men than women, which is consistent with the male predomi-
nance in the dialysis population. We found the ESRF popula-
tion to be significantly younger than the non-ESRF population
(mean age 57.3 years versus 59.5 years), which is in contrast
to the work of Clermont and coworkers [6], who did not find a
significant difference in age between ESRF and non-ESRF
patients. This finding raises the possibility that there could be
a denial of access to the ICU for the dialysis population on the
basis of age. The greater serum creatinine and lower haemat-
ocrit observed in the dialysis population was not unexpected,
possibly reflecting acute complications directly attributable to
the underlying disease such as pulmonary oedema or
hyperkalaemia.
In the present series, patients with ESRF were found to have
greater severity of illness than the non-ESRF population on
admission to the ICU, as defined by both the Acute Physiology
Score (17.2 versus 12.6) and APACHE II score (24.7 versus
16.6); this is consistent with the findings of earlier studies
[6,7,18]. This implies that ESRF patients are not being denied
entry to ICU on the basis of severity of illness; rather, it raises
the issue of whether late referral or acceptance of dialysis
patients to ICU is influencing the findings. Some of this differ-
ence in severity of illness at admission between ESRF and
non-ESRF patients could be explained by our findings that
there was a significant difference in the disease aetiology
between the two groups. There were significantly more
nonsurgical admissions in the ESRF population (66.7% ver-
sus 56.2%), and a greater proportion of this group was admit-
Table 3
Mortality by number of nonrenal organ system failures in patients requiring chronic renal dialysis as compared with other 
admissions
Number of nonrenal organ system failuresa Ultimate hospital mortality (deaths/admissions [%])
Admissions requiring chronic renal dialysis Admissions not requiring chronic renal dialysis
0 289/1,036 (27.9) 14,825/100,125 (14.8)
1 469/1,077 (43.5) 28,071/92,242 (30.4)
2 413/662 (62.4) 24,118/43,545 (55.4)
3 172/228 (75.4) 9,967/12,907 (77.2)
4 36/44 (81.8) 888/997 (89.1)
aOrgan system failures assessed physiologically, according to the method of Knaus and coworkers [10].
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Table 4
Effects of age, sex, surgical status, APACHE II physiological variables, serum albumin and number of organ system failures on 
ultimate hospital outcome in patients requiring chronic renal dialysis
Parameter Patients requiring chronic renal dialysis Admissions not requiring chronic renal dialysis
Deaths n (%) Adjusted OR (95% CI) P valuee Adjusted OR (95% CI) P valuef
Age (years)* 1.28 (1.20–1.36) < 0.001 1.50 (1.49–1.52) <0.001
< 45 223 681 (32.8) per 10-year increase per 10-year increase
45–54 234 499 (46.9)
55–64 314 711 (44.2)
65–74 398 805 (49.4)
75+ 210 351 (59.8)
Sex 0.145 0.653
Female 546 1,220 (44.8) Reference Reference
Male 833 1,827 (45.6) 1.15 (0.95–1.38) 1.10 (1.07–1.12)
Surgical status* < 0.001 <0.001
Elective surgery 124 548 (22.6) Reference Reference
Emergency surgery 194 486 (39.9) 1.69 (1.23–2.32) 2.49 (2.40–2.59)
Nonsurgical 1,061 2,012 (52.7) 2.10 (1.59–3.78) 3.83 (3.69–3.97)
Past medical history* 0.042 0.111
Absent 1,121 2,563 (43.7) Reference Reference
Present 258 484 (53.3) 1.29 (1.01–1.64) 1.57 (1.52–1.62)
CPR before admission* < 0.001 0.424
No 1,083 2,621 (41.3) Reference Reference
Yes 295 423 (69.7) 1.90 (1.44–2.52) 2.14 (2.05–2.22)
LOS before admission (days)* < 0.001 0.053
0 378 863 (43.8) Reference Reference
1–2 198 595 (33.3) 0.76 (0.58–1.00) 0.99 (0.96–1.02)
2–3 94 240 (39.2) 0.98 (0.69–1.40) 1.09 (1.04–1.14)
3–6 197 448 (44.0) 0.95 (0.71–1.27) 1.29 (1.24–1.34)
7+ 511 900 (56.8) 1.95 (1.52–2.49) 1.86 (1.80–1.93)
Temperaturea (°C) 0.783 0.078
< 34 80 126 (63.5) 1.24 (0.77–1.99) 1.96 (1.84–2.08)
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34–36 456 946 (48.2) 1.05 (0.85–1.30) 1.23 (1.19–1.26)
36–38.5 465 1,208 (38.5) Reference Reference
38.5–39 120 274 (43.8) 1.16 (0.85–1.59) 0.95 (0.91–0.98)
≥ 39 193 382 (50.5) 1.13 (0.84–1.51) 1.10 (1.06–1.13)
Mean arterial pressurea (mmHg)* < 0.001 <0.001
< 50 410 596 (68.8) 1.96 (1.36–2.83) 1.96 (1.87–2.04)
50–70 575 1,189 (48.4) 1.29 (0.95–1.75) 1.21 (1.17–1.25)
70–110 117 351 (33.3) Reference Reference
110–130 144 496 (29.0) 0.74 (0.52–1.05) 0.96 (0.92–1.00)
≥ 130 100 357 (28.0) 0.62 (0.42–0.92) 1.26 (1.20–1.32)
Heart rateb (beats/min)* < 0.001 0.638
< 50 86 168 (51.2) 1.34 (0.88–2.06) 1.15 (1.08–1.22)
50–100 242 780 (31.0) Reference Reference
100–110 170 446 (38.1) 1.23 (0.92–1.64) 1.11 (1.07–1.16)
110–120 228 486 (46.9) 1.57 (1.18–2.08) 1.37 (1.32–1.42)
120–140 373 697 (53.5) 1.81 (1.40–2.36) 1.72 (1.66–1.77)
140–155 137 241 (56.9) 1.86 (1.30–2.66) 2.15 (2.06–2.24)
≥ 155 107 162 (66.0) 2.09 (1.35–3.23) 2.52 (2.40–2.64)
Respiratory rateb (breaths/min)* < 0.001 0.082
< 6 63 121 (52.1) 0.99 (0.60–1.64) 1.22 (1.15–1.30)
6–12 357 881 (40.5) 1.11 (0.84–1.46) 1.07 (1.04–1.11)
12–14 230 496 (46.4) 1.38 (1.01–1.88) 1.23 (1.19–1.27)
14–25 207 503 (41.2) Reference Reference
25–35 269 627 (42.9) 1.13 (0.84–1.51) 0.99 (0.96–1.03)
35–40 115 190 (60.5) 2.11 (1.40–3.18) 1.25 (1.19–1.32)
≥ 40 96 148 (64.9) 2.32 (1.46–3.68) 1.49 (1.41–1.56)
Oxygenationb (mmHg)* 0.025 0.003
A-aDO2 (FiO2 ≥ 0.5)
< 250 92 182 (50.6) Reference Reference
250–350 187 332 (56.3) 1.28 (0.96–1.72) 1.28 (1.24–1.32)
350–500 109 200 (54.5) 0.73 (0.49–1.07) 1.56 (1.48–1.63)
Table 4 (Continued)
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≥ 500 164 242 (67.8) 1.26 (0.87–1.84) 1.70 (1.63–1.77)
PaO2 (FiO2 < 0.5)
< 50 33 61 (54.1) 1.53 (0.80–2.93) 1.06 (0.97–1.16)
50–70 130 295 (44.1) 1.04 (0.77–1.41) 0.95 (0.92–0.99)
70–80 128 343 (37.3) 0.78 (0.58–1.04) 0.91 (0.87–0.94)
≥ 80 352 846 (41.6) Reference Reference
Arterial pHa* < 0.001 0.985
< 7.15 156 190 (82.1) 2.65 (1.68–4.18) 2.95 (2.78–3.13)
7.15–7.25 157 248 (63.3) 1.53 (1.08–2.16) 1.65 (1.59–1.72)
7.25–7.33 248 544 (45.6) 1.16 (0.92–1.47) 1.20 (1.16–1.23)
7.33–7.5 559 1,380 (40.5) Reference Reference
≥ 7.5 79 153 (51.6) 1.40 (0.95–2.07) 1.40 (1.33–1.48)
Serum sodiuma (mmol/l)* 0.035 0.079
< 130 174 331 (52.6) 1.44 (1.09–1.90) 1.43 (1.37–1.48)
130–150 1,069 2,468 (43.3) Reference Reference
≥ 150 41 64 (64.1) 1.12 (0.61–2.07) 2.26 (2.14–2.39)
Serum potassiuma (mmol/l) 0.180 <0.001
< 3 68 125 (54.4) 1.15 (0.74–1.78) 1.09 (1.04–1.14)
3–3.5 199 379 (52.5) 1.16 (0.89–1.52) 0.99 (0.96–1.02)
3.5–5.5 658 1,482 (44.4) Reference Reference
5.5–6 143 351 (40.7) 0.91 (0.68–1.21) 1.26 (1.19–1.32)
6–7 145 370 (39.2) 0.74 (0.55–0.99) 1.39 (1.31–1.48)
≥ 7 68 153 (44.4) 0.84 (0.55–1.28) 1.40 (1.25–1.56)
Serum creatininea (mg/100 ml) 0.295 0.095
< 1.5 21 73 (28.8) Reference Reference
1.5–2 28 67 (41.8) 0.55 (0.28–1.08) 1.05 (1.02–1.09)
2–3.5 152 307 (49.5) 0.90 (0.58–1.39) 1.37 (1.32–1.42)
≥ 3.5 1,048 2,365 (44.3) 0.80 (0.55–1.15) 1.25 (1.18–1.32)
Serum albuminb (g/l)* < 0.001 0.060
< 20 453 823 (55.0) 1.50 (1.20–1.87) 1.37 (1.34–1.41)
Table 4 (Continued)
Effects of age, sex, surgical status, APACHE II physiological variables, serum albumin and number of organ system failures on 
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20–25 239 501 (47.7) 1.35 (1.05–1.72) 1.00 (0.97–1.03)
≥ 25 350 990 (35.4) Reference Reference
Haematocrita (%) 0.133 0.002
< 20 164 324 (50.6) 0.70 (0.49–1.01) 1.26 (1.18–1.34)
20–30 790 1,769 (44.7) 0.86 (0.70–1.06) 1.16 (1.14–1.19)
≥ 30 326 751 (43.4) Reference Reference
White blood counta (× 1,000/mm3)* 0.021 0.884
< 3 92 129 (71.3) 2.02 (1.26–3.25) 1.70 (1.60–1.79)
3–15 586 1,577 (37.2) Reference Reference
15–20 252 533 (47.3) 1.05 (0.83–1.33) 1.13 (1.10–1.17)
20–40 287 508 (56.5) 1.28 (1.00–1.64) 1.26 (1.22–1.30)
≥ 40 32 48 (66.7) 1.34 (0.67–2.70) 1.38 (1.25–1.53)
Glasgow Coma Scorec* 1.12 (1.09–1.15) < 0.001 1.09 (1.09–1.09) 0.067
3–6 360 466 (77.3) per decrease of 1 per decrease of 1
7–9 73 138 (52.9)
10–12 77 161 (47.8)
13–15 756 2,044 (37.0)
Organ system failuresd* 1.25 (1.07–1.46) 0.005 1.31 (1.28–1.33) 0.561
0 289 1,036 (27.9) per increase of 1 per increase of 1
1 469 1,077 (43.6)
2 413 662 (62.4)
3+ 208 272 (76.5)
Sepsis* 0.022 0.060
No 785 2,035 (38.6) Reference Reference
Yes 594 1,012 (58.7) 1.28 (1.04–1.57) 1.04 (1.02–1.07)
A total of 2,922 patients are included in this analysis. Significant factors (P < 0.05) in the model for admissions of patients requiring chronic renal dialysis are 
highlighted by asterisks. Exclusions are as follows: readmissions within the same hospital stay; and admissions missing age, sex, surgical status, temperature, mean 
arterial pressure, heart rate or respiratory rate. Those admissions with missing values for any other physiological variables were assumed to be normal and placed in the 
reference category. aCategories from Acute Physiology and Chronic Health Evaluation (APACHE) II (reference category equivalent to zero APACHE II points). 
bCategories from APACHE III (reference category equivalent to zero APACHE III points). cPre-sedation values used for admissions sedated or paralyzed during the first 
24 hours in intensive care unit (ICU). dOrgan system failures assessed physiologically, in accordance with the method of Knaus and coworkers [10]. eP value for 
significance of factor in the end-stage renal failure (ESRF) model. fP value for difference between ESRF and non-ESRF models (test of interaction). A-aDO2, alveolar-
arterial oxygen difference; CI, confidence interval; CPR, cardiopulmonary resuscitation; FiO2, fractional inspired oxygen; LOS, length of stay; OR, odds ratio; PaO2, 
arterial oxygen tension.
Table 4 (Continued)
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ted following CPR. It is not possible from our analysis to
determine whether the ESRF group who required pre-admis-
sion CPR suffered a primary cardiac arrhythmia, the incidence
of which is known to be increased in this patient population.
The admission cause was coded as chronic renal failure in a
small percentage of the ESRF cohort. This probably reflects a
direct acute complication of renal failure such as volume over-
load or electrolyte disturbance.
Somewhat surprisingly, we found that the length of ICU stay
was equivalent between the two groups of patients, despite
the ESRF patients being sicker and having greater comorbid-
ity. Many UK renal units have considerable experience in the
care of critically ill patients with renal disease, thus allowing
earlier ICU discharge. This finding is consistent with the find-
ings of Clermont and coworkers [6]. However, the ESRF pop-
ulation had a significantly longer hospital stay following
discharge from ICU (25 days versus 17 days in the non-ESRF
group for hospital survivors). There was also a marked differ-
ence in readmission rates between the two groups (9.0% in
ESRF patients versus 4.7% in non-ESRF patients). These fig-
ures could provide a basis for estimating the minimum service
required to provide ICU services for the ESRF population and
the costs of this service.
The large numbers included in the present study enabled us to
achieve statistically significant confirmation of the suggestions
made by Clermont [6] and Dara [5] and their coworkers,
namely that the increased mortality observed in the ESRF pop-
ulation in the ICU setting is significantly lower than the
increased mortality seen with ARF in the ICU setting. We
found that the mortality at discharge from the ICU was 5.5%
higher in the ESRF population (26.3% versus 20.8% in the
non-ESRF population). This increased ICU mortality probably
reflects the increased severity of illness seen in this popula-
tion. However, the mortality rate was considerably lower than
that seen in a contemporaneous population of patients for
whom ARF was recorded as the primary cause of ICU admis-
sion in an analysis of the same database (43.3%) [19].
Although increased mortality is seen in the ESRF population
admitted to ICU, the mortality rate is considerably lower than
that seen in the ARF population.
The ultimate hospital mortality in the ESRF population was
45.3% (95% CI 43.5% to 47.0%), as compared with 31.2%
(95% CI 31.0% to 31.4%) in the non-ESRF population.
Although this represents a significantly increased mortality in
the ESRF group, it once again is much lower than the ultimate
hospital mortality seen in the population of patients with ARF
as their primary reason for ICU admission in the same dataset
(58.6%) [19]. This difference is even more marked when one
examines subgroups of the ARF population, such as those
patients presenting with oliguric ARF to the ICU, who have an
ultimate hospital mortality of 70.3% [19]. When examining out-
comes for number of organ system failures, we found the
ESRF population to have a higher mortality with a lower
number of nonrenal organ failures.
We demonstrated significant differences in outcome between
the two groups in terms of increased hospital stay following
discharge from the ICU, increased rate of readmission to ICU
and increased ultimate hospital mortality. It is likely that there
are multiple reasons for these differences in outcome between
the two groups. These include issues such as lack of physio-
logical reserve in the dialysis population, and the well
described increased rates of hospital-acquired infections in
Figure 3
Comparison between APACHE II and the ESRF-specific model in discriminating between survivors and nonsurvivorsi i i i i i r   r i r . Shown are receiver operating 
characteristic curves for APACHE II and the ESRF-specific model from Table 4 for patients admitted to intensive care units requiring and not requir-
ing chronic renal dialysis. APACHE, Acute Physiology and Chronic Health Evaluation; ESRF, end stage renal failure (requiring chronic renal dialysis).
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the ESRF population, including a high rate of staphylococcal
bacteraemia and Clostridium difficile infection [20-22]. There
is also the ongoing need for vascular and peritoneal access,
with their corresponding complications; all of these probably
contribute to these differences in outcome. Drawing from
these significant differences in outcome, it may be that current
management of the ESRF population following ICU discharge
is suboptimal in England, Wales and Northern Ireland. There
may be a greater need for closer post-ICU monitoring and
increased focus on intermediate care, including rehabilitation.
This requires further investigation but it does raise the possi-
bility that, with adequate resource planning and delivery, it may
well be possible to reduce some of these differences.
Analysis of factors that affect outcome in the ESRF group
revealed no real surprises. Significant factors were older age;
surgical status; physiological extremes such as hypotension,
bradycardia, tachypnoea and hypoxia; biochemical derange-
ment with hyponatraemia, sepsis and leucopenia; and the
number of additional nonrenal organ system failures. A number
of the factors examined exhibited either a stronger or weaker
relationship to outcome in the ESRF population than in the
non-ESRF population.
Analysis of ROC curves demonstrated that the APACHE II
score's discrimination of patient outcome in the ESRF popula-
tion was worse than that among patients admitted to ICU who
did not require dialysis. This is consistent with previous work
in patients with ARF admitted to the ICU. Lins and coworkers
[23] demonstrated that the APACHE II score is a less sensi-
tive predictor of outcome in the ARF setting than are renal-
specific scoring systems such as the Stuivenberg Hospital
Acute Renal Failure system [23]. This should be considered in
any clinical decision-making process in patients with ESRF
being considered for admission to the ICU.
Conclusion
Patients with dialysis-dependent ESRF who are admitted to
UK ICUs are more likely to be younger and male, with a medi-
cal cause of admission, and to have greater severity of illness
than the non-ESRF population. Despite this, ICU stay was sim-
ilar and ICU mortality for patients with ESRF was only margin-
ally increased. Nevertheless, patients with ESRF had
increased ICU readmission rates, prolonged hospital stay and
greater post-ICU mortality as compared with the general ICU
population. Patient outcomes were considerably better than
those reported for patients with ARF admitted to the ICU. This
report may facilitate planning of adequate ICU resources for
this population. It may also inform the clinical decision process
surrounding ICU admission for patients receiving chronic dial-
ysis therapy.
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